Sterling Powerg. (513575)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Positive ROCE of 11.42% suggests the operating capital base generates some return.
• Latest quarter still recorded ₹1 Cr in sales, so the company is not a hollow shell.
• No dividend obligation currently, so any cash generated is not being diverted to shareholders.
• Piotroski F-Score of 4/9 is weak but not zero, indicating some financial signals are not entirely negative.

Concerns

• P/E of 0.00 and negative quarterly net profit mean there are no earnings to justify the valuation.
• Extremely negative ROE of -87.94% and P/B of 26.19 show severe value destruction priced at a huge premium.
• Sales growth and profit growth are both 0%, while dividend yield is also 0%.
• Promoter holding is N/A and debt/equity is N/A, creating a lack of transparency that a value investor cannot ignore.

AI Analysis

When I look at Sterling Powerg, the first thing I ask is: what am I actually buying here? The market cap is ₹24 Cr, but the book value per share is only ₹1.71, and the price is ₹44.78. That means I am being asked to pay more than 26 times the net worth of the company. At the same time, the reported P/E is 0.00, which is not a sign of cheapness — it is a sign that there are no positive earnings to base a valuation on. The latest quarter shows sales of just ₹1 Cr and a net profit of essentially negative ₹0 Cr. Sales growth is 0%, profit growth is 0%, and there is no dividend. This is not a business that gives me any margin of safety. The ROE is an eye-watering -87.94%, meaning the tiny equity base is being eroded badly. Interestingly, ROCE is positive at 11.42%, which suggests the operating assets can generate some return, but that does not translate into shareholder value when the equity return is so deeply negative. Debt-to-equity is not available, and promoter holding is not disclosed either, so even the transparency I need cannot be confirmed. The Piotroski F-Score of 4/9 tells me the financial health is weak. The stock is trading near its 52-week high, but price action means nothing to me if the underlying business cannot compound capital. This is not a compounder, not a stalwart, and certainly not an asset play at 26 times book value. It may one day be a turnaround, but today there is no evidence of a durable recovery. I would need to see real profitability, growing sales, and honest disclosures before I would even begin to consider this. Until then, this is a speculation, not an investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer